ABLYNX (ABLYF) Set to Announce Earnings on Thursday

ABLYNX (OTCMKTS:ABLYF) will be announcing its earnings results after the market closes on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.21) per share for the quarter.

ABLYNX (OTCMKTS:ABLYF) opened at $52.00 on Wednesday. ABLYNX has a one year low of $11.10 and a one year high of $54.75.

Several equities analysts recently issued reports on ABLYF shares. Zacks Investment Research upgraded ABLYNX from a “hold” rating to a “buy” rating and set a $28.00 price objective on the stock in a research note on Monday, January 8th. Bank of America started coverage on ABLYNX in a research note on Friday, November 10th. They set a “buy” rating and a $26.00 price objective on the stock. Finally, ValuEngine upgraded ABLYNX from a “sell” rating to a “hold” rating in a research note on Friday, February 2nd.

ILLEGAL ACTIVITY NOTICE: “ABLYNX (ABLYF) Set to Announce Earnings on Thursday” was published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://www.thelincolnianonline.com/2018/02/21/ablynx-ablyf-set-to-announce-earnings-on-thursday.html.

About ABLYNX

Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, immuno-oncology, oncology, and respiratory diseases.

Receive News & Ratings for ABLYNX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABLYNX and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply